Future Financial Wealth Managment LLC Has $134,000 Stock Position in CVS Health Co. (NYSE:CVS)

Future Financial Wealth Managment LLC cut its position in shares of CVS Health Co. (NYSE:CVS) by 40.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,979 shares of the pharmacy operator’s stock after selling 1,996 shares during the period. Future Financial Wealth Managment LLC’s holdings in CVS Health were worth $134,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of the company. MidAtlantic Capital Management Inc. acquired a new position in CVS Health in the third quarter worth $25,000. Ridgewood Investments LLC boosted its stake in CVS Health by 255.7% in the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 450 shares in the last quarter. Livelsberger Financial Advisory acquired a new position in CVS Health in the third quarter worth $31,000. Legacy Investment Solutions LLC acquired a new position in CVS Health in the third quarter worth $31,000. Finally, Reston Wealth Management LLC acquired a new position in CVS Health in the third quarter worth $32,000. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Performance

Shares of CVS traded up $3.39 during mid-day trading on Monday, reaching $51.40. The company’s stock had a trading volume of 17,679,697 shares, compared to its average volume of 14,000,489. The stock has a market cap of $64.68 billion, a P/E ratio of 13.05, a PEG ratio of 0.85 and a beta of 0.59. The business has a 50-day simple moving average of $51.82 and a two-hundred day simple moving average of $56.55. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.08 by $0.01. The business had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period last year, the firm posted $2.21 EPS. As a group, equities research analysts anticipate that CVS Health Co. will post 5.32 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be given a $0.665 dividend. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 5.18%. CVS Health’s payout ratio is 67.51%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on CVS shares. StockNews.com lowered CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. Deutsche Bank Aktiengesellschaft raised CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price on the stock in a research note on Tuesday, December 3rd. Cantor Fitzgerald restated a “neutral” rating and issued a $62.00 price target on shares of CVS Health in a report on Tuesday, October 1st. Mizuho lowered their price target on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. Finally, Evercore ISI increased their price target on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $68.71.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.